Sign in
4

Changes in Ownership

Aldeyra Therapeutics, Inc. Filed Acc 0000950170-24-097071

Chief Development Officer sold 16,041 shares at $4.74 ($75,975)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Machatha Stephen Chief Development Officer 2024-08-12 Sale −16,041 $4.74 $75,975 236,771 D: show line 1 in the form
Open-market sales · 16,041 sh · avg $4.74 · $75,975
Loading xslF345X05/ownership.xml…